BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans
MWN-AI** Summary
BlackRock recently announced updates to the managed distribution plans for three of its funds: BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX). The changes will take effect with the distribution occurring in October 2025. The updated plans will transition from floating rate distributions to a more stable level rate distribution, which is anticipated to enhance distribution stability while remaining competitive.
For each fund, clear monthly distribution rates have been set. BMEZ will distribute $0.110 per share, BSTZ $0.1625, and BTX $0.0525. The Board of Trustees approved these changes in an effort to balance investment income from public and private investment sources while maintaining the potential for growth in net asset value.
Moreover, under BlackRock’s managed distribution framework, all available income will be distributed to shareholders in alignment with regulatory requirements. If the funds’ cumulative income is insufficient, distributions may include long-term capital gains or return of capital to maintain consistent payouts. It is essential for shareholders to be aware that a return of capital does not reflect the funds' investment performance; rather, it may decrease the net asset value per share.
Investors can access updated information regarding performance and distribution rates on BlackRock’s website. The changes are subject to regulatory compliance and the discretion of the respective Funds' Boards, ensuring ongoing adjustments in response to market conditions. BlackRock emphasizes its commitment to providing financial accessibility and performance clarity for its clientele.
MWN-AI** Analysis
BlackRock’s recent updates to the managed distribution plans for its funds—BMEZ, BSTZ, and BTX—mark a significant shift towards a more stable distribution approach. With these changes taking effect in October 2025, each fund will move from a floating rate distribution to a level rate distribution, with set monthly payouts of $0.11000, $0.16250, and $0.05250 respectively. This transition aims to enhance predictability and may lead to more investor confidence as distributions become more stable.
For investors, this news might indicate a compelling entry point into these funds. The projected distributions, while reduced from prior amounts, still offer competitive rates, and the shift to fixed distributions may attract those seeking consistent income streams. Additionally, managing public and private investments more effectively could improve each fund's overall performance, particularly in uncertain market environments.
However, it’s crucial for potential investors to consider the underlying risk factors. Given that distributions may involve a return of capital, this could imply that the funds are returning part of the investors' original investment rather than solely generating income from realized gains. This aspect could raise concerns over net asset value depletion in the long-term if the funds consistently distribute more than they earn.
Investors should also be mindful of market conditions that could influence these funds going forward, particularly macroeconomic factors and sector-specific trends. The healthcare, technology, and private equity sectors—central to these funds' investment strategies—face varying levels of potential volatility.
In conclusion, while this distribution update presents an opportunity for income-focused investors, careful analysis of the funds' underlying performance and market conditions is essential. Investors are advised to monitor these developments closely and consider their individual risk tolerance before investing.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
The Board of Trustees (the "Board") of BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX) (the “Funds”) approved updates to each Fund’s managed distribution plan that will take effect with the October 2025 distribution. The Funds will change from a floating rate distribution to a level rate distribution at the stated monthly rates provided below. These changes seek to enhance distribution stability while maintaining a competitive distribution rate and offering the potential to grow each Fund’s net asset value. Additionally, these changes will help to manage the proportion of public and private investments.
Equity Funds:
Declaration- 9/10/2025 Ex-Date- 10/15/2025 Record- 10/15/2025 Payable- 10/31/2025
Fund | Ticker | Distribution | Change From Prior Distribution |
BMEZ | $0.11000 | (0.052910) | |
BSTZ | $0.16250 | (0.055620) | |
BTX | $0.05250 | (0.025920) |
* In order to comply with the requirements of Section 19 of the Investment Company Act of 1940, as amended (the “1940 Act”), each of the Funds noted above posted to the DTC bulletin board and sent to its shareholders of record as of the applicable record date a Section 19 notice with the previous distribution payment. The Section 19 notice was provided for informational purposes only and not for tax reporting purposes. This information can be found in the “Closed-End Funds” section of www.blackrock.com . As applicable, the final determination of the source and tax characteristics of all distributions in 2025 will be made after the end of the year.
The fixed amounts distributed per share or distribution rate, as applicable, are subject to change at the discretion of each Fund’s Board of Directors/Trustees. Under its Plan, each Fund will distribute all available investment income to its shareholders, consistent with its investment objectives and as required by the Internal Revenue Code of 1986, as amended (the “Code”). If sufficient income (inclusive of net investment income and short-term capital gains) is not available on a monthly basis, a Fund will distribute long-term capital gains and/or return capital to its shareholders in order to maintain a level distribution.
Each Fund’s estimated sources of the distributions paid as of August 29, 2025 and for its current fiscal year are as follows:
Estimated Allocations as of August 29, 2025 | |||||
Fund | Distribution | Net Income | Net Realized Short-Term Gains | Net Realized Long-Term Gains | Return of Capital |
BMEZ 1 | $0.164960 | $0 (0%) | $0 (0%) | $0 (0%) | $0.164960 (100%) |
BSTZ | $0.216470 | $0 (0%) | $0 (0%) | $0.216470 (100%) | $0 (0%) |
BTX 1 | $0.078840 | $0 (0%) | $0 (0%) | $0 (0%) | $0.078840 (100%) |
Estimated Allocations for the Fiscal Year through August 29, 2025 | |||||
Fund | Distribution | Net Income | Net Realized Short-Term Gains | Net Realized Long-Term Gains | Return of Capital |
BMEZ 1 | $1.378150 | $0 (0%) | $0 (0%) | $0 (0%) | $1.378150 (100%) |
BSTZ | $1.756800 | $0 (0%) | $0 (0%) | $1.756800 (100%) | $0 (0%) |
BTX 1 | $0.665550 | $0 (0%) | $0 (0%) | $0 (0%) | $0.665550 (100%) |
1 The Fund estimates that it has distributed more than its income and net-realized capital gains in the current fiscal year; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment is paid back to the shareholder. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with ‘yield’ or ‘income’. When distributions exceed total return performance, the difference will reduce the Fund’s net asset value per share.
The amounts and sources of distributions reported are only estimates and are being provided to you pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon each Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
Fund Performance and Distribution Rate Information: | ||||
Fund | Average annual total return (in relation to NAV) for the 5-year period ending on 07/31/2025 | Annualized current distribution rate expressed as a percentage of NAV as of 07/31/2025 | Cumulative total return (in relation to NAV) for the fiscal year through 07/31/2025 | Cumulative fiscal year distributions as a percentage of NAV as of 07/31/2025 |
BMEZ | (0.18%) | 13.04% | 0.14% | 7.99% |
BSTZ | 5.85% | 11.37% | 6.71% | 6.74% |
BTX* | (11.19%) | 12.32% | (0.34%) | 7.64% |
* Portfolio launched within the past 5 years; the performance and distribution rate information presented for this Fund reflects data from inception to 7/31/2025.
Shareholders should not draw any conclusions about a Fund’s investment performance from the amount of the Fund’s current distributions or from the terms of the Fund’s Plan.
The amount distributed per share under a Plan is subject to change at the discretion of the applicable Fund’s Board. Each Plan will be subject to ongoing review by the Board to determine whether the Plan should be continued, modified or terminated. The Board may amend the terms of a Plan or suspend or terminate a Plan at any time without prior notice to the Fund’s shareholders if it deems such actions to be in the best interest of the Fund or its shareholders. The amendment or termination of a Plan could have an adverse effect on the market price of the Fund's shares.
About BlackRock
BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate .
Availability of Fund Updates
BlackRock will update performance and certain other data for the Fund on a monthly basis on its website in the “Closed-end Funds” section of www.blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about the Fund. This reference to BlackRock’s website is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate BlackRock’s website in this release.
Forward-Looking Statements
This press release, and other statements that BlackRock or the Fund may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the Fund’s or BlackRock’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.
BlackRock cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and BlackRock assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.
With respect to the Fund, the following factors, among others, could cause actual events to differ materially from forward-looking statements or historical performance: (1) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets, which could result in changes in demand for the Fund or in the Fund’s net asset value; (2) the relative and absolute investment performance of the Fund and its investments; (3) the impact of increased competition; (4) the unfavorable resolution of any legal proceedings; (5) the extent and timing of any distributions or share repurchases; (6) the impact, extent and timing of technological changes; (7) the impact of legislative and regulatory actions and reforms, and regulatory, supervisory or enforcement actions of government agencies relating to the Fund or BlackRock, as applicable; (8) terrorist activities, international hostilities, health epidemics and/or pandemics and natural disasters, which may adversely affect the general economy, domestic and local financial and capital markets, specific industries or BlackRock; (9) BlackRock’s ability to attract and retain highly talented professionals; (10) the impact of BlackRock electing to provide support to its products from time to time; and (11) the impact of problems at other financial institutions or the failure or negative performance of products at other financial institutions.
Annual and Semi-Annual Reports and other regulatory filings of the Fund with the Securities and Exchange Commission (“SEC”) are accessible on the SEC's website at www.sec.gov and on BlackRock’s website at www.blackrock.com , and may discuss these or other factors that affect the Fund. The information contained on BlackRock’s website is not a part of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250910678068/en/
1-800-882-0052
FAQ**
How does the change to a level rate distribution for the BlackRock Health Sciences Trust II of Beneficial Interest BMEZ enhance distribution stability compared to the previous floating rate distribution?
What factors led to the Board's decision to implement a managed distribution plan for BlackRock Health Sciences Trust II of Beneficial Interest BMEZ, and how might this affect investor confidence?
In light of the estimated allocations indicating a return of capital for BlackRock Health Sciences Trust II of Beneficial Interest BMEZ, what implications does this have for shareholders' long-term investment strategy?
How might changes in market conditions and investment performance impact the distribution rate and overall investment objectives of BlackRock Health Sciences Trust II of Beneficial Interest BMEZ in the upcoming fiscal year?
**MWN-AI FAQ is based on asking OpenAI questions about BlackRock Health Sciences Term Trust of Beneficial Interest (NYSE: BMEZ).
NASDAQ: BMEZ
BMEZ Trading
2.01% G/L:
$14.20 Last:
108,841 Volume:
$14.06 Open:



